Skip to main content

Nobel Prize for Medicine to Researchers Who Discovered New Way To Treat Cancer

Medically reviewed by Drugs.com.

We have entered a new era of Cancer chemotherapy, thanks largely in part to the work of two passionate researchers in the field, James Allison of the University of Texas and Dr. Tasuku Honjo from Kyoto University in Japan.

This week, both men were awarded the Nobel Prize in Medicine for their discovery of two different proteins on T-cells which act like brakes on a car, preventing our immune system from attacking our own normal cells. Their investigations showed that cancer can also activate these “brakes” (called checkpoints), preventing the destruction of cancer cells by our immune system.

This revelation paved the way for the development of checkpoint inhibitors, the first drugs of their kind to work by focusing on our immune system, rather than just targeting cancer cells. Checkpoint inhibitors block cancer cells from binding to checkpoints on T-cells, effectively releasing the “brakes” and allowing our T-cells to proliferate and attack cancer cells. Other scientists have since discovered several more molecular “brakes”, opening up a whole new avenue of anti-cancer targets.

For more information on checkpoint inhibitors see here.

Read this next

ESPN's Jay Harris Diagnosed With Prostate Cancer

FRIDAY, June 6, 2025 — Longtime ESPN “SportsCenter” anchor Jay Harris has been diagnosed with prostate cancer and is scheduled to have surgery on June...

Immunotherapy Effective Against Stomach Cancer

FRIDAY, June 6, 2025 — Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical trial says. People treated...

Fluoride Ban Could Create Cavities For 1 Of Every 3 U.S. Kids

MONDAY, June 2, 2025 — Removing fluoride from the U.S. water supply could result in more than 25 million more decayed teeth in children and teenagers within five years, a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.